News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Smith Devin Whittemore
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/09/2023 |
4
| Smith Devin Whittemore (General Counsel) has filed a Form 4 on IO Biotech, Inc.
Txns:
| Granted 4,938 shares
@ $1.9, valued at
$9.4k
Granted 4,938 warrants
@ $2.47, valued at
$12.2k
|
|
01/13/2023 |
4
| Smith Devin Whittemore (General Counsel) has filed a Form 4 on IO Biotech, Inc.
Txns:
| Granted 150,000 options to buy
@ $2.6, valued at
$390k
|
|
01/13/2023 |
3
| Smith Devin Whittemore (General Counsel) has filed a Form 3 on IO Biotech, Inc. |
12/06/2022 |
4
| Smith Devin Whittemore (SVP and General Counsel) has filed a Form 4 on YUMANITY THERAPEUTICS, INC.
Txns:
| Sold 3,116 shares
@ $1.691, valued at
$5.3k
|
|
06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
10/14/2020 |
4
| Smith Devin Whittemore (SVP and General Counsel) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 85,000 options to buy
@ $3.5, valued at
$297.5k
|
|
08/17/2020 |
4
| Smith Devin Whittemore (SVP and General Counsel) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 153,531 options to buy
@ $7.11, valued at
$1.1M
|
|
01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/13/2018 |
4
| Smith Devin Whittemore (SVP and General Counsel) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 120,000 options to buy
@ $7.96, valued at
$955.2k
|
|
08/02/2018 |
4
| Smith Devin Whittemore (SVP and General Counsel) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 200,000 options to buy
@ $7.95, valued at
$1.6M
|
|
08/02/2018 |
3
| Smith Devin Whittemore (SVP and General Counsel) has filed a Form 3 on Minerva Neurosciences, Inc. |
|
|